![]() |
Course: BHS210 First Term: 2021 Fall
Final Term: Current
Final Term: 2023 Summer
|
Lecture 3.0 Credit(s) 3.0 Period(s) 3.0 Load
Credit(s) Period(s)
Load
Subject Type: OccupationalLoad Formula: S - Standard Load |
MCCCD Official Course Competencies | |||
---|---|---|---|
1. Describe the major historical and contemporary themes related to addictions and substance abuse disorders, including common myths and stereotypes. (I)
2. Identify the major categories of drugs of abuse/misuse and describe their primary effects, including complications and withdrawal symptoms. (II) 3. Describe behavioral, psychological, physiological, familial and sociocultural factors important to the development of addiction and drug use. (III) 4. Explain the potential impact of crisis and other trauma-causing events on the development of addictive behavior and substance use. (III) 5. Describe the relapse and recovery process and the factors that affect the probability of both relapse and recovery. (IV) 6. Describe the role of self-help groups and 12-step programs in addiction recovery and relapse prevention. (V) 7. Describe addiction prevention and treatment modalities and levels of care. (V) 8. Describe ethical and legal considerations related to substance abuse and addiction treatment. (VI) 9. Explain the importance of healthcare literacy to treatment access and options. (VII) | |||
MCCCD Official Course Competencies must be coordinated with the content outline so that each major point in the outline serves one or more competencies. MCCCD faculty retains authority in determining the pedagogical approach, methodology, content sequencing, and assessment metrics for student work. Please see individual course syllabi for additional information, including specific course requirements. | |||
MCCCD Official Course Outline | |||
I. Historical overview of addiction, alcohol and other drugs
A. Historical concepts of addiction and treatment B. Major themes and events C. Legislation II. Licit and illicit drugs: primary effects, complications, and withdrawal A. Narcotic analgesics (Opiates) B. Central nervous system (CNS) depressants C. CNS stimulants (Sympathomimetics) D. Hallucinogens E. Cannabis F. Inhalants G. Synthetic drugs H. Alcohol I. Nicotine J. Other III. Models of addiction development A. Medical model 1. Genetic factors 2. Disease concept B. Psychological factors C. Sociocultural factors D. Role of family and systemic factors E. Impact of trauma F. Integrated, bio-psycho-social considerations IV. Overview of relapse and recovery process A. Definition and description B. Relapse warning signs C. Transtheoretical model: stages of change D. Relapse prevention V. Understanding treatment of addiction A. Levels of care and associated treatment goals 1. Detoxification, inpatient,intensive-outpatient, outpatient 2. Sober living environments and halfway houses B. Transtheoretical model: Processes of change 1. Cognitive and affective experiential processes 2. Behavioral processes C. Models of treatment 1. Medication assisted a. Antabuse b. Naltrexone c. Buprenorphine/Naloxone d. Methadone 2. Cognitive and behavioral interventions 3. Self-help groups and 12-step programs 4. Role of the family 5. Abstinence vs. harm reduction VI. Ethical, legal and professional issues in providing treatment A. Ethical considerations and decision making B. Addiction and the legal system C. Professional organizations, standards and competencies D. Certifications VII. Access to addiction treatment A. Domains and levels of healthcare literacy B. Constraints on treatment options available C. Using assistance of a healthcare navigator | |||
MCCCD Governing Board Approval Date: June 26, 2018 |